NESS ZIONA, ISRAEL – MeaTech 3D Ltd., a developer of industrial-scale cultivated meat production technologies, recently filed a provisional patent application in the US Patent Office (USPTO) that directly relates to MeaTech’s cellular agriculture 3D bioprinting goals to produce premium cuts of meat made from animal cells.
The company is developing advanced manufacturing technologies to produce cultured meat products, and the patent application is for a novel method for bioprinting that MeaTech believes can provide “exceptional control of bio-ink printing during multi-layered bioprinting processes.”
“This novel technique for achieving more controlled, higher resolution printing may prove to be a promising path forward towards achieving high-throughput, large-scale cultivated meat production,” said Sharon Fima, chief executive officer of MeaTech. “As a 20-year veteran of the printing industry, I recognize the significant potential this patent application holds, as it directly addresses key challenges currently facing the bioprinting industry.”
MeaTech’s target customers are value-added food producers to make advanced cultivated meat and related products. The company’s goal is to minimize the use of natural resources, improve animal welfare and meet the growing demand for sustainable animal proteins.
“The novel technology allows for significant control during in situ inkjet printing of each droplet size, the volume of droplets, and the precise placement of the droplets onto a sacrificial substrate layer,” the company explained. “MeaTech believes these attributes could allow for bioprinting resolutions that are highly advantageous in achieving premium, thick meat emulating products.”